Sa Lv

1.5k total citations
24 papers, 1.2k citations indexed

About

Sa Lv is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Sa Lv has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Sa Lv's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Sa Lv is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Sa Lv collaborates with scholars based in China, United States and Macao. Sa Lv's co-authors include Zheng Zhang, Junliang Fu, Ruonan Xu, Hu Lin, Ming Shi, Hua Geng, Fu‐Sheng Wang, Zhengsheng Zou, Liming Chen and Hongli Song and has published in prestigious journals such as Hepatology, Scientific Reports and European Journal of Immunology.

In The Last Decade

Sa Lv

23 papers receiving 1.2k citations

Peers

Sa Lv
Sa Lv
Citations per year, relative to Sa Lv Sa Lv (= 1×) peers Yutaka Yata

Countries citing papers authored by Sa Lv

Since Specialization
Citations

This map shows the geographic impact of Sa Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sa Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sa Lv more than expected).

Fields of papers citing papers by Sa Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sa Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sa Lv. The network helps show where Sa Lv may publish in the future.

Co-authorship network of co-authors of Sa Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Sa Lv. A scholar is included among the top collaborators of Sa Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sa Lv. Sa Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Sa, Xiaogang Hao, Weiwei Chen, et al.. (2025). Model Prediction of Infection Risk After Glucocorticoid Treatment for Severe Drug-Induced Liver Injury: Globulin is a Core Predictive Factor. Drug Design Development and Therapy. Volume 19. 6871–6883.
2.
Lv, Yifan, Bing Zhu, Dongze Li, et al.. (2024). Stratified analysis of the correlation between wedged hepatic venous pressure and portal venous pressure in patients with portal hypertension. Scientific Reports. 14(1). 29210–29210. 2 indexed citations
3.
Song, Fangjiao, Hongling Liu, Ying Sun, et al.. (2023). Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled study. PubMed. 2(3). 156–162. 3 indexed citations
4.
Zhu, Bing, Shaoli You, Yihui Rong, et al.. (2020). A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure. Brazilian Journal of Medical and Biological Research. 53(11). e9728–e9728. 5 indexed citations
6.
Zhang, Ji‐Yuan, Sa Lv, Huan Wang, et al.. (2014). Interleukin-33 Promotes Disease Progression in Patients with Primary Biliary Cirrhosis. The Tohoku Journal of Experimental Medicine. 234(4). 255–261. 19 indexed citations
7.
Zhou, Lin, Huaming Wang, Junliang Fu, et al.. (2013). Study on the correlation between CD4~+ cytotoxic T and course of primary hepatocellular carcinoma. Jiefangjun yixue zazhi. 38(2). 137–140. 1 indexed citations
8.
Feng, Guohua, Ji‐Yuan Zhang, Qing‐Lei Zeng, et al.. (2013). Interleukin‐21 mediates hepatitis B virus‐associated liver cirrhosis by activating hepatic stellate cells. Hepatology Research. 44(10). E198–205. 16 indexed citations
9.
Zhang, Ji‐Yuan, Xiaoli Wu, Bin Yang, et al.. (2013). Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C. European Journal of Immunology. 43(7). 1953–1962. 10 indexed citations
10.
Zhang, Zheng, Hu Lin, Ming Shi, et al.. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology. 27(s2). 112–120. 273 indexed citations
11.
Wang, Wen, et al.. (2011). Tumor necrosis factor-α affects blood–brain barrier permeability in acetaminophen-induced acute liver failure. European Journal of Gastroenterology & Hepatology. 23(7). 552–558. 28 indexed citations
12.
Wang, Siyu, et al.. (2011). [Increase in peripheral and liver infiltrating regulatory T cells favors development of primary hepatocellular carcinoma].. PubMed. 27(6). 668–70. 2 indexed citations
13.
Lv, Sa, Hongli Song, Ying Zhou, et al.. (2010). Tumour necrosis factor-α affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver International. 30(8). 1198–1210. 104 indexed citations
14.
Wang, Jianghua, Dong Jiang, Henghui Zhang, et al.. (2009). Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2. PROTEOMICS. 9(6). 1672–1682. 24 indexed citations
15.
16.
Feng, Bo, Sheng Wu, Sa Lv, et al.. (2009). A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice. BMC Gastroenterology. 9(1). 99–99. 10 indexed citations
17.
Feng, Bo, Shengming Wu, Sa Lv, et al.. (2008). Dynamic metabonomic analysis of BALB/C mice with different outcomes after D-galactosamine/lipopolysaccharide–induced fulminant hepatic failure. Liver Transplantation. 14(11). 1620–1631. 9 indexed citations
18.
Lv, Sa, Jianghua Wang, Feng Liu, et al.. (2008). Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay. BMC Gastroenterology. 8(1). 17–17. 22 indexed citations
19.
Feng, Bo, Shengming Wu, Sa Lv, et al.. (2007). Metabolic Profiling Analysis of a d-Galactosamine/Lipopolysaccharide-Induced Mouse Model of Fulminant Hepatic Failure. Journal of Proteome Research. 6(6). 2161–2167. 56 indexed citations
20.
Lv, Sa, Lai Wei, Jianghua Wang, Jingyan Wang, & Feng Liu. (2007). Identification of Novel Molecular Candidates for Acute Liver Failure in Plasma of BALB/c Murine Model. Journal of Proteome Research. 6(7). 2746–2752. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026